Category: Medicine and Healthcare

AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities
Press Release Jul 30, 2024
AmplifyBio Partners with Industry Leader in Lipid Nanoparticles (LNPs) to Expand Drug Delivery Capabilities
AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity
Press Release Nov 7, 2023
AmplifyBio Selects Apprentice.io’s Tempo Manufacturing Execution System to Supercharge Manufacturing Capabilities as They Expand Capacity
AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share Capabilities that Enhance the Safety and Scalability of Lentiviral-based Gene Therapeutics
Press Release Oct 31, 2023
AmplifyBio and Vector BioMed Partner to Manufacture Plasmids and Share Capabilities that Enhance the Safety and Scalability of Lentiviral-based Gene Therapeutics
AmplifyBio Celebrates 2 Years of Innovative Solutions, Preclinical Drug Development and Safety
Press Release May 25, 2023
AmplifyBio Celebrates 2 Years of Innovative Solutions, Preclinical Drug Development and Safety
AmplifyBio Adds Manufacturing Capabilities to Expand Service Portfolio
Press Release May 15, 2023
AmplifyBio Adds Manufacturing Capabilities to Expand Service Portfolio

AmplifyBio is adding manufacturing services, starting with cell therapy and plasmids, to its growing capabilities to support the safe development of advanced therapies.
Dispatch Media Group Names AmplifyBio a Winner of The Columbus Top Workplaces 2023 Award
Press Release Apr 3, 2023
Dispatch Media Group Names AmplifyBio a Winner of The Columbus Top Workplaces 2023 Award
AmplifyBio Emerges as a Leader in Cell Therapy Characterization, Filling a Gap in Pre-Clinical Development
Press Release Mar 16, 2023
AmplifyBio Emerges as a Leader in Cell Therapy Characterization, Filling a Gap in Pre-Clinical Development

AmplifyBio builds on the T-cell immunology expertise of its South San Francisco-based team, adding technology platforms and capabilities in single-cell analysis and product assessment in the context of a tumor microenvironment.
AmplifyBio Secures $50M in Debt Financing With Hercules Capital to Accelerate Business Plan
Press Release Jan 12, 2023
AmplifyBio Secures $50M in Debt Financing With Hercules Capital to Accelerate Business Plan

AmplifyBio announces $50M in debt financing to accelerate the expansion of its service offering, supporting the rapid, safe development of next-generation therapeutics
AmplifyBio Celebrates One Year Since Launch With an Expansion of Capabilities and Capacity and a New Site
Press Release Jul 12, 2022
AmplifyBio Celebrates One Year Since Launch With an Expansion of Capabilities and Capacity and a New Site

A preclinical CRO built for the future on a foundation of experience: amplify-bio.com